Literature DB >> 22930885

PET/CT in oncology.

Gary J Cook.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22930885      PMCID： PMC4952129          DOI： 10.7861/clinmedicine.12-4-368

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  4 in total

1.  Use of (18)F-FDG PET/CT to locate primary malignancies in patients with hepatic cirrhosis and malignant ascites.

Authors:  He-Bin Fan; Ai-Jun Wang; Dong-Liang Yang; Jun Xiao; Yun Ai; Lu Huang; Yong Guo; Mu-Xiu Zhou; Juan-Juan Wu; Zhi Li; Fu-Ming Yan; Yi-Ming Wang
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

2.  Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients.

Authors:  Maya Paran; Katerina Shulman; Boris Kessel; Jasmin Dagan
Journal:  Rambam Maimonides Med J       Date:  2022-04-26

Review 3.  PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology.

Authors:  Sara S Rinne; Anna Orlova; Vladimir Tolmachev
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 4.  Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis.

Authors:  Synnøve Nymark Aasen; Heidi Espedal; Olivier Keunen; Tom Christian Holm Adamsen; Rolf Bjerkvig; Frits Thorsen
Journal:  Neurooncol Adv       Date:  2021-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.